Skip to main content

Advertisement

Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus

Fig. 3

Distribution of IFN-high subsets among SLE patients with different characteristics. The figure illustrates how subsets of different IFN types distribute among patients with active SLE manifestations (a), past manifestations and events (b), positivity for autoantibodies (c) and laboratory parameters (d) (presented in %) as assessed at inclusion. Abbreviations: LN lupus nephritis, NPSLE neuropsychiatric SLE (*at inclusion, NPSLE was classified by 1982 ACR criteria, seizures or psychosis), aCL anti-cardiolipin, B2GP1 β2glycoprotein-I, LA lupus anticoagulant, ESR erythrocyte sedimentation rate, WBC white blood cells, PLT platelets. Only patients in whom all four measurements were available are included in the analysis (n = 248)

Back to article page